Question

I am a breastfeeding mother and i want to know if it is safe to use Immunoglobulin G4-kappa, bispecific, anti-(homo sapiens F9a (activated coagulation factor F9, activated coagulation factor IX) and anti-(homo sapiens F10 (coagulation factor 10, coagulation factor X))? Is Immunoglobulin G4-kappa, bispecific, anti-(homo sapiens F9a (activated coagulation factor F9, activated coagulation factor IX) and anti-(homo sapiens F10 (coagulation factor 10, coagulation factor X)) safe for nursing mother and child? Does Immunoglobulin G4-kappa, bispecific, anti-(homo sapiens F9a (activated coagulation factor F9, activated coagulation factor IX) and anti-(homo sapiens F10 (coagulation factor 10, coagulation factor X)) extracts into breast milk? Does Immunoglobulin G4-kappa, bispecific, anti-(homo sapiens F9a (activated coagulation factor F9, activated coagulation factor IX) and anti-(homo sapiens F10 (coagulation factor 10, coagulation factor X)) has any long term or short term side effects on infants? Can Immunoglobulin G4-kappa, bispecific, anti-(homo sapiens F9a (activated coagulation factor F9, activated coagulation factor IX) and anti-(homo sapiens F10 (coagulation factor 10, coagulation factor X)) influence milk supply or can Immunoglobulin G4-kappa, bispecific, anti-(homo sapiens F9a (activated coagulation factor F9, activated coagulation factor IX) and anti-(homo sapiens F10 (coagulation factor 10, coagulation factor X)) decrease milk supply in lactating mothers?

Answer by DrLact: About Immunoglobulin G4-kappa, bispecific, anti-(homo sapiens F9a (activated coagulation factor F9, activated coagulation factor IX) and anti-(homo sapiens F10 (coagulation factor 10, coagulation factor X)) usage in lactation

No information is available on the clinical use of Immunoglobulin G4-kappa, bispecific, anti-(homo sapiens F9a (activated coagulation factor F9, activated coagulation factor IX) and anti-(homo sapiens F10 (coagulation factor 10, coagulation factor X)) during breastfeeding. Because Immunoglobulin G4-kappa, bispecific, anti-(homo sapiens F9a (activated coagulation factor F9, activated coagulation factor IX) and anti-(homo sapiens F10 (coagulation factor 10, coagulation factor X)) is a large protein molecule with a molecular weight of 145,600, the amount in milk is likely to be very low and absorption is unlikely because it is probably destroyed in the infant's gastrointestinal tract.

Alternate Drugs

Trastuzumab(Unsafe)
Cetuximab(Unsafe)
Secukinumab(Low Risk)
Nivolumab(Unsafe)
Ustekinumab(Low Risk)
Denosumab(Low Risk)
Omalizumab(Low Risk)
Ipilimumab(Unsafe)
Rituximab(Low Risk)
Abciximab(Low Risk)
Basiliximab(Low Risk)
Bevacizumab(Low Risk)
Belimumab(Low Risk)
Natalizumab(Low Risk)
Cetuximab(Unsafe)
Cisplatin(Unsafe)
Gemcitabine(Dangerous)
Busulfan(Dangerous)
Carboplatin(Dangerous)
Cladribine(Dangerous)
Erlotinib(Unsafe)
Imatinib(Unsafe)
Paclitaxel(Dangerous)
Nivolumab(Unsafe)
Vinblastine(Dangerous)
Fluorouracil(Dangerous)
Dasatinib(Unsafe)
Alemtuzumab(Low Risk)
Dactinomycin(Dangerous)
Nilotinib(Unsafe)
Vincristine(Dangerous)
Bleomycin(Dangerous)
Ipilimumab(Unsafe)
Tamoxifen(Dangerous)
Vinorelbine(Dangerous)
Rituximab(Low Risk)
Mitoxantrone(Dangerous)
Letrozole(Dangerous)
Dacarbazine(Dangerous)
Docetaxel(Dangerous)
Exemestane(Dangerous)
Bevacizumab(Low Risk)
Hydroxyurea(Low Risk)
Thioguanine(Dangerous)
Etoposide(Dangerous)
Doxorubicin(Dangerous)
Pazopanib(Unsafe)
Cyclophosphamide(Dangerous)
Trastuzumab(Unsafe)

Synonyms of Immunoglobulin G4-kappa, bispecific, anti-(homo sapiens F9a (activated coagulation factor F9, activated coagulation factor IX) and anti-(homo sapiens F10 (coagulation factor 10, coagulation factor X))

Disclaimer: Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. We do not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.